Company · CIK 1709941
BioAge Labs, Inc.
| CIK | 1709941 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BIOA (Nasdaq) |
| First annual or quarterly report | 2024-11-07 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294568 | 2026-03-24 | 2026-03-24 | 1 | |
| 333-290688 | 2025-10-02 | 2026-01-22 | 3 | |
| 333-290690 | 2025-10-02 | 2025-10-02 | 1 | |
| 333-281901 | 2024-09-03 | 2024-09-26 | 5 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-24 | S-3ASRShelf registered | 333-294568 | 0001193125-26-121862 |
| 2026-01-22 | 424B5Shelf takedown | 333-290688 | 0001193125-26-019530 |
| 2026-01-20 | 424B5Shelf takedown | 333-290688 | 0001193125-26-016537 |
| 2025-10-02 | S-3Shelf registered | 333-290690 | 0001193125-25-228452 |
| 2025-10-02 | S-3Shelf registered | 333-290688 | 0001193125-25-228414 |
| 2024-09-26 | 424B4Final prospectus | 333-281901 | 0001193125-24-226927 |
| 2024-09-25 | EFFECTDeclared effective | 333-281901 | 9999999995-24-002965 |
| 2024-09-25 | S-1/AAmendment | 333-281901 | 0001193125-24-225155 |
| 2024-09-18 | S-1/AAmendment | 333-281901 | 0001193125-24-221367 |
| 2024-09-03 | S-1Registration filed | 333-281901 | 0001193125-24-212046 |
| 2024-05-31 | DRSDraft made public | 377-07253 | 0000950123-24-006073 |